TotalMarketCap

Alx Oncology

ALXONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$143.038 M

$1.15 -15.81%

Close of 6 Nov 2026

As of 6 Nov 2026, Alx Oncology (ALXO) has a market capitalization of $143.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$101.7M

Loss-making

Shares outstanding

138,276,997

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #265Atrium TherapeuticsRNA$143.5M
  2. #266MacrogenicsMGNX$143.3M
  3. #267Alx OncologyALXO$143.0M
  4. #268Nervgen PharmaNGEN$141.0M
  5. #269Veraxa Biotech AG - Post de-SPACVRXA$139.4M

What if Alx Oncology were worth as much as…

Open the what-if tool →

Gold $28.2T

$226,033.12

Per share 197,409× higher

Bitcoin $1.53T

$12,230.26

Per share 10,681× higher

Apple $5.02T

$40,150.80

Per share 35,066× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Alx Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.